We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CENCOMALLS:BCSCencosud Shopping SA Analysis

Data as of 2026-03-17 - not real-time

CLP 2,380.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cencosud Shopping trades at a price that sits above its discounted cash‑flow estimate, suggesting limited upside from an intrinsic‑value perspective. However, its price‑to‑earnings multiple is well under the sector average, positioning the stock as a relative value play. The dividend yield of nearly four percent and a payout ratio just above half of earnings provide an attractive income component. Analysts project a modest upside of around ten percent, reinforcing the view that the market price is not dramatically stretched. The short‑term moving average trails the medium‑term average while both remain above the long‑term average, indicating a neutral trend with a slight bias to the downside. Momentum metrics such as the fourteen‑day relative strength index sit in the low‑forties, lacking bullish momentum. The MACD histogram is negative and the signal line is bearish, aligning with the recent decline in trading volume. Volatility is elevated, reflecting sizable price swings, yet the stock’s beta is low, implying limited correlation with broader market moves. The balance sheet shows a high leverage profile, with debt far exceeding equity, which could constrain flexibility under adverse conditions. Strong operating cash flow and free cash flow generation help mitigate some of the debt concerns and support the dividend. Given the blend of modest valuation appeal, solid cash generation, and income, the medium‑term outlook leans toward a buying stance. In the short run, technical weakness and falling volume advise caution, while the long‑run perspective remains cautious‑optimistic pending improvements in leverage and market sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD and negative histogram
  • declining volume trend
  • neutral moving‑average crossover

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E well below industry average
  • solid dividend yield and payout ratio
  • moderate upside potential relative to fair value

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high debt‑to‑equity ratio
  • strong cash flow supporting dividend
  • low beta offset by elevated volatility

Key Metrics & Analysis

Financial Health

Revenue Growth3.90%
Profit Margin80.15%
P/E Ratio13.4
ROE10.39%
ROA6.21%
Debt/Equity27.17
P/B Ratio1.4
Op. Cash FlowCLP272.4B
Free Cash FlowCLP269.0B
Industry P/E32.8

Technical Analysis

TrendNeutral
RSI41.4
SupportCLP 0.00
ResistanceCLP 2,699.90
MA 20CLP 2,491.38
MA 50CLP 2,561.86
MA 200CLP 2,227.06
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCLP 2,080.84
Target PriceCLP 2,634.29
Upside/Downside10.68%
GradeFair
TypeValue
Dividend Yield3.82%

Risk Assessment

Beta0.26
Volatility42.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.